Extensively, CD155, CD112 and CD113 are over-expressed in several solid tumors (pancreatic cancer, glioblastoma, colon cancer, ovarian cancer, etc.)and affect cell proliferation, migration invasion and adhesion by regulating tumor-associated signaling pathways [18,19,20,21]. The gene discussed is PVR; the disease is neoplasm.